Canada markets closed
  • S&P/TSX

    17,909.03
    -49.06 (-0.27%)
     
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • DOW

    30,814.26
    -177.26 (-0.57%)
     
  • CAD/USD

    0.7857
    -0.0054 (-0.68%)
     
  • CRUDE OIL

    52.04
    -1.53 (-2.86%)
     
  • BTC-CAD

    45,851.24
    +275.73 (+0.60%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • GOLD FUTURES

    1,827.70
    -23.70 (-1.28%)
     
  • RUSSELL 2000

    2,123.20
    -32.15 (-1.49%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • NASDAQ

    12,998.50
    -114.14 (-0.87%)
     
  • VOLATILITY

    24.34
    +1.09 (+4.69%)
     
  • FTSE

    6,735.71
    -66.25 (-0.97%)
     
  • NIKKEI 225

    28,519.18
    -179.08 (-0.62%)
     
  • CAD/EUR

    0.6500
    -0.0004 (-0.06%)
     

Nikola, JetBlue fall; Moderna, Novavax rise

·1 min read

NEW YORK — Stocks that moved heavily or traded substantially Monday:

Moderna Inc., up $25.71 to $152.74.

The biotechnology company said it would ask U.S. and European regulators to allow emergency use of its COVID-19 vaccine.

S&P Global Inc., up $10.21 to $351.78.

The financial information company is buying data provider IHS Markit in a $44 billion all-stock deal.

Slack Technologies Inc., up $2.21 to $42.88.

Salesforce.com is reportedly preparing to buy the work-messaging company, according to media reports.

Nikola Corp., down $7.52 to $20.41.

General Motors abandoned a planned $2 billion investment in the electric vehicle maker.

JetBlue Airways Corp., down 62 cents to $15.09.

The airline warned investors its revenue would fall sharply during the fourth quarter.

Facebook Inc., down 84 cents to $276.97.

The social media company faces new federal and state antitrust lawsuits, according to the Wall Street Journal.

Carnival Corp., down $1.60 to $19.98.

Concerns over rising virus cases weighed on cruise line operators and other companies that depend on travellers .

Novavax Inc., up $13.81 to $139.50.

The biotechnology company gave investors an encouraging update on its program to develop a COVID-19 vaccine.

slowdown in store traffic but strong online spending.

The Associated Press